The company has wide range of multiple usage and single usage Respirator solutions to treat respiratory diseases. Respirator solutions are useful to treat acute exacerbation in asthma and COPD. It is suitable and convenient for all age group.
Recently BEXIMCO Pharma introduces First time in Bangladesh Mucolytic and Antibiotic as Sterile Respirator Solution.
Azmasol Respirator Solution
(Respirator Solution Salbutamol 5 mg/ml)
Azmasol® Respirator Solution is an aqueous solution of Salbutamol Sulphate BP. Salbutamol is one of a group of medicines called bronchodilators or 'relievers' and it is a 2- adrenoceptor agonist, used in the treatment of asthma and other forms of diffuse reversible airways obstruction.
Iprasol Respirator Solution
( Ipratropium Bromide BP 20 mcg/ 250mcg actuation )
Ipramid is a preperation of Ipratropium bromide which is a anticholinergic agent that works as a bronchodilator that dilates the bronchi in the lungs. It is used in treating chronic obstructive pulmonary disease associated with chronic bronchitis and emphysema. In chronic obstructive pulmonary disease, cholinergic nerves going to the lungs cause narrowing of the bronchi by stimulating the muscles surrounding the bronchi to contract. An "anti-cholinergic" effect of ipratropium bromide blocks the effect of the cholinergic nerves, causing the muscles to relax and the bronchi to dilate.
Ipramid Respirator Solution
( Salbutamol 100 mcg & Ipratropium Bromide BP 20 mcg /actuation )
Iprasol is a preparation of Salbutamol & Ipratropium bromide.Salbutamol is a beta2-adrenergic agent which acts on airway smooth muscle resulting in relaxation. Ipratropium Bromide is a anticholinergic agent that works as a bronchodilator that dilates the bronchi in the lungs. Iprasol provides the simultaneous release of ipratropium bromide and salbutamol allowing the synergistic efficacy on the muscarinic and beta2-adrenergic receptors in the airways to cause bronchodilation which is superior to that provided by each single agent and with no potentiation of adverse events.
Tobasol Respirator Solution
(Tobramycin USP 300 mg/5 ml)
Tobasol® Respirator Solution is an aqueous solution of Tobramycin. Tobramycin is an aminoglycoside antibiotic and acts primarily by disrupting protein synthesis, leading to altered cell membrane permeability, and eventual cell death. Tobramycin is bactericidal and is active against wide range of Gram-negative organisms including Pseudomonas aeruginosa.
Mucomist Respirator Solution
(Acetylcysteine USP 200 mg/ ml)
Mucomist® Respirator Solution is a derivative of the amino acid, cysteine. It acts mostly on the mucoproteins, through its free sulphydryl groups, to open disulphide bonds and lower the viscosity of the mucus. Furthermore, acetylcysteine exerts an antioxidant action by interacting directly with the oxidant radicals. The action of acetylcysteine in limiting hepatotoxicity after paracetamol (acetaminophen) overdosage is probably due to the replenishing of hepatic stores of glutathione.